MDs on Botox Utility (MOBILITY)

CompletedOBSERVATIONAL
Enrollment

1,372

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
BlepharospasmTorticollisStrabismusMuscle Spasticity
Interventions
OTHER

botulinum toxin type A

There will be no protocol-mandated intervention with regard to physician treatment choice or management of patient condition once the patient is enrolled in the project.

Trial Locations (1)

Unknown

Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY